| Product NDC: | 0363-2529 |
| Proprietary Name: | Bronchial Asthma Relief |
| Non Proprietary Name: | Ephedrine HCl, Guaifenesin |
| Active Ingredient(s): | 12.5; 200 mg/1; mg/1 & nbsp; Ephedrine HCl, Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0363-2529 |
| Labeler Name: | Walgreens Company |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20020213 |
| Package NDC: | 0363-2529-67 |
| Package Description: | 4 BLISTER PACK in 1 CARTON (0363-2529-67) > 15 TABLET in 1 BLISTER PACK |
| NDC Code | 0363-2529-67 |
| Proprietary Name | Bronchial Asthma Relief |
| Package Description | 4 BLISTER PACK in 1 CARTON (0363-2529-67) > 15 TABLET in 1 BLISTER PACK |
| Product NDC | 0363-2529 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Ephedrine HCl, Guaifenesin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020213 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Walgreens Company |
| Substance Name | EPHEDRINE HYDROCHLORIDE; GUAIFENESIN |
| Strength Number | 12.5; 200 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |